Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer.

Bekelman JE, Zelefsky MJ, Jang TL, Basch EM, Schrag D.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1456-66. Epub 2007 Aug 8.

PMID:
17689880
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.

Mantz CA, Song P, Farhangi E, Nautiyal J, Awan A, Ignacio L, Weichselbaum R, Vijayakumar S.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):551-7.

PMID:
9112452
[PubMed - indexed for MEDLINE]
3.

Variations in quality of care for men with early-stage prostate cancer.

Spencer BA, Miller DC, Litwin MS, Ritchey JD, Stewart AK, Dunn RL, Gay EG, Sandler HM, Wei JT.

J Clin Oncol. 2008 Aug 1;26(22):3735-42. doi: 10.1200/JCO.2007.13.2555.

PMID:
18669460
[PubMed - indexed for MEDLINE]
4.

The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement.

Cheung AK, Chen MH, Moran BJ, Braccioforte MH, Dosoretz DE, Salenius S, Katin M, Ross R, D'Amico AV.

Brachytherapy. 2010 Apr-Jun;9(2):145-50. doi: 10.1016/j.brachy.2009.08.001.

PMID:
20346894
[PubMed - indexed for MEDLINE]
5.

Treatment choice and quality of care for men with localized prostate cancer.

Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS.

Med Care. 2007 May;45(5):401-9.

PMID:
17446826
[PubMed - indexed for MEDLINE]
6.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID:
10802358
[PubMed - indexed for MEDLINE]
7.

Physician visits prior to treatment for clinically localized prostate cancer.

Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM, Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D.

Arch Intern Med. 2010 Mar 8;170(5):440-50. doi: 10.1001/archinternmed.2010.1.

PMID:
20212180
[PubMed - indexed for MEDLINE]
8.

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer.

Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):8-15. doi: 10.1016/j.ijrobp.2011.06.1951. Epub 2011 Nov 11.

PMID:
22079721
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.

Quek RG, Master VA, Ward KC, Lin CC, Virgo KS, Portier KM, Lipscomb J.

Cancer. 2013 Oct 15;119(20):3619-28. doi: 10.1002/cncr.28258. Epub 2013 Jul 31.

PMID:
23913478
[PubMed - indexed for MEDLINE]
10.

The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.

Shen X, Keith SW, Mishra MV, Dicker AP, Showalter TN.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1154-9. doi: 10.1016/j.ijrobp.2011.09.055. Epub 2012 Jan 21.

PMID:
22270175
[PubMed - indexed for MEDLINE]
11.

Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.

Mantz CA, Nautiyal J, Awan A, Kopnick M, Ray P, Kandel G, Niederberger C, Ignacio L, Dawson E, Fields R, Weichselbaum R, Vijayakumar S.

Cancer J Sci Am. 1999 Jul-Aug;5(4):230-6.

PMID:
10439169
[PubMed - indexed for MEDLINE]
12.

Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon.

Gerard JP, Xie C, Carrie C, Romestaing P, Pommier P, Mornex F, Clippe S, Sentenac I, Ginestet C.

Aust N Z J Surg. 1999 Oct;69(10):707-11.

PMID:
10527346
[PubMed - indexed for MEDLINE]
13.

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):614-23.

PMID:
11597800
[PubMed - indexed for MEDLINE]
14.

Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.

Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):684-90.

PMID:
15183471
[PubMed - indexed for MEDLINE]
15.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
[PubMed - indexed for MEDLINE]
16.

Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.

Sher DJ, Neville BA, Chen AB, Schrag D.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e197-206. doi: 10.1016/j.ijrobp.2011.02.007. Epub 2011 May 17.

PMID:
21596483
[PubMed - indexed for MEDLINE]
17.
18.

External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.

Hoffman KE, Hong TS, Zietman AL, Russell AH.

Cancer. 2008 Feb 15;112(4):943-9.

PMID:
18098220
[PubMed - indexed for MEDLINE]
Free Article
19.

Regional variation in quality of prostate cancer care.

Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Hollingsworth JM, Shahinian VB, Hollenbeck BK.

J Urol. 2014 Apr;191(4):957-62. doi: 10.1016/j.juro.2013.10.066. Epub 2013 Oct 19.

PMID:
24144685
[PubMed - indexed for MEDLINE]
20.

Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.

Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson JH, Bin L.

J Clin Oncol. 1996 Aug;14(8):2258-65.

PMID:
8708715
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk